Ozempic for Alzheimer’s? How GLP-1 Weight-Loss Drugs Could Fight Neurodegenerative Diseases
GLP-1 Receptor Agonists and Neurodegenerative Diseases in 2025 GLP-1 receptor agonists like semaglutide (Ozempic®) are typically given via a weekly injection pen. Originally developed for diabetes and obesity, these drugs are now being studied for their effects on the brain. From Diabetes to Dementia: Why GLP-1 Drugs Are Being Tested for Brain Diseases Just a few years ago, GLP-1 receptor agonists were known mainly as diabetes and weight-loss medications. GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate blood sugar and appetite. Drugs like Ozempic (semaglutide) and Victoza (liraglutide) mimic this hormone, improving insulin release and promoting a feeling